77 related articles for article (PubMed ID: 12704395)
1. Modified apoptotic molecule (BID) reduces hepatitis C virus infection in mice with chimeric human livers.
Hsu EC; Hsi B; Hirota-Tsuchihara M; Ruland J; Iorio C; Sarangi F; Diao J; Migliaccio G; Tyrrell DL; Kneteman N; Richardson CD
Nat Biotechnol; 2003 May; 21(5):519-25. PubMed ID: 12704395
[TBL] [Abstract][Full Text] [Related]
2. The nonstructural proteins of the hepatitis C virus: structure and functions.
Neddermann P; Tomei L; Steinkühler C; Gallinari P; Tramontano A; De Francesco R
Biol Chem; 1997 Jun; 378(6):469-76. PubMed ID: 9224925
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of hepatic injury in coinfection with hepatitis C virus and HIV.
Balasubramanian A; Koziel M; Groopman JE; Ganju RK
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S32-7. PubMed ID: 16265611
[TBL] [Abstract][Full Text] [Related]
4. The NS3 protein of hepatitis C virus induces caspase-8-mediated apoptosis independent of its protease or helicase activities.
Prikhod'ko EA; Prikhod'ko GG; Siegel RM; Thompson P; Major ME; Cohen JI
Virology; 2004 Nov; 329(1):53-67. PubMed ID: 15476874
[TBL] [Abstract][Full Text] [Related]
5. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
[TBL] [Abstract][Full Text] [Related]
6. [Virology of hepatitis C virus].
Hofmann H
Wien Med Wochenschr; 2000; 150(23-24):463-6. PubMed ID: 11205175
[TBL] [Abstract][Full Text] [Related]
7. Practical evaluation of a mouse with chimeric human liver model for hepatitis C virus infection using an NS3-4A protease inhibitor.
Kamiya N; Iwao E; Hiraga N; Tsuge M; Imamura M; Takahashi S; Miyoshi S; Tateno C; Yoshizato K; Chayama K
J Gen Virol; 2010 Jul; 91(Pt 7):1668-77. PubMed ID: 20164258
[TBL] [Abstract][Full Text] [Related]
8. The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic.
Tsantrizos YS
Biopolymers; 2004; 76(4):309-23. PubMed ID: 15386268
[TBL] [Abstract][Full Text] [Related]
9. Effect of hepatitis C virus infection on the mRNA expression of drug transporters and cytochrome p450 enzymes in chimeric mice with humanized liver.
Kikuchi R; McCown M; Olson P; Tateno C; Morikawa Y; Katoh Y; Bourdet DL; Monshouwer M; Fretland AJ
Drug Metab Dispos; 2010 Nov; 38(11):1954-61. PubMed ID: 20693416
[TBL] [Abstract][Full Text] [Related]
10. Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse.
Vanwolleghem T; Meuleman P; Libbrecht L; Roskams T; De Vos R; Leroux-Roels G
Gastroenterology; 2007 Oct; 133(4):1144-55. PubMed ID: 17919490
[TBL] [Abstract][Full Text] [Related]
11. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
[TBL] [Abstract][Full Text] [Related]
12. Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model.
El-Gogo S; Staib C; Lasarte JJ; Sutter G; Adler H
J Gene Med; 2008 Feb; 10(2):177-86. PubMed ID: 18076128
[TBL] [Abstract][Full Text] [Related]
13. Development of a cell-based assay for monitoring hepatitis C virus ns3/4a protease activity.
Lei YF; Yin W; Yang J; Lv X; Wei SH; An QX; Hu XB; Xu ZK
Acta Virol; 2008; 52(3):133-41. PubMed ID: 18999887
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
[TBL] [Abstract][Full Text] [Related]
15. Host cell killing by the West Nile Virus NS2B-NS3 proteolytic complex: NS3 alone is sufficient to recruit caspase-8-based apoptotic pathway.
Ramanathan MP; Chambers JA; Pankhong P; Chattergoon M; Attatippaholkun W; Dang K; Shah N; Weiner DB
Virology; 2006 Feb; 345(1):56-72. PubMed ID: 16243374
[TBL] [Abstract][Full Text] [Related]
16. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
Wu SJ; Ng LT; Lin CC
Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126
[TBL] [Abstract][Full Text] [Related]
17. Redesigning the substrate specificity of the hepatitis C virus NS3 protease.
Failla CM; Pizzi E; Francesco RD; Tramontano A
Fold Des; 1995; 1(1):35-42. PubMed ID: 9162139
[TBL] [Abstract][Full Text] [Related]
18. HCV non-structural NS4A protein of genotype 3a induces mitochondria mediated death by activating Bax and the caspase cascade.
Javed F; Manzoor S
Microb Pathog; 2018 Nov; 124():346-355. PubMed ID: 30179714
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription.
Taniguchi H; Kato N; Otsuka M; Goto T; Yoshida H; Shiratori Y; Omata M
J Med Virol; 2004 Jan; 72(1):52-9. PubMed ID: 14635011
[TBL] [Abstract][Full Text] [Related]
20. Cadmium induces apoptotic cell death in WI 38 cells via caspase-dependent Bid cleavage and calpain-mediated mitochondrial Bax cleavage by Bcl-2-independent pathway.
Oh SH; Lee BH; Lim SC
Biochem Pharmacol; 2004 Nov; 68(9):1845-55. PubMed ID: 15450950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
